Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2002 Jan 8;99(1):113-7.
doi: 10.1073/pnas.012584599. Epub 2001 Dec 18.

Regulatory DNA required for vnd/NK-2 homeobox gene expression pattern in neuroblasts

Affiliations

Regulatory DNA required for vnd/NK-2 homeobox gene expression pattern in neuroblasts

Xiaoping Shao et al. Proc Natl Acad Sci U S A. .

Erratum in

  • Proc Natl Acad Sci U S A 2002 Jun 11;99(12):8458-9

Abstract

Vnd/NK-2 protein was detected in 11 neuroblasts per hemisegment in Drosophila embryos, 9 medial and 2 intermediate neuroblasts. Fragments of DNA from the 5'-flanking region of the vnd/NK-2 gene were inserted upstream of an enhancerless betagalactosidase gene in a P-element and used to generate transgenic fly lines. Antibodies directed against Vnd/NK-2 and beta-galactosidase proteins then were used in double-label experiments to correlate the expression of beta-galactosidase and Vnd/NK-2 proteins in identified neuroblasts. DNA region A, which corresponds to the -4.0 to -2.8-kb fragment of DNA from the 5'-flanking region of the vnd/NK-2 gene was shown to contain one or more strong enhancers required for expression of the vnd/NK-2 gene in ten neuroblasts. DNA region B (-5.3 to -4.0 kb) contains moderately strong enhancers for vnd/NK-2 gene expression in four neuroblasts. Hypothesized DNA region C, whose location was not identified, contains one or more enhancers that activate vnd/NK-2 gene expression only in one neuroblast. These results show that nucleotide sequences in at least three regions of DNA regulate the expression of the vnd/NK-2 gene, that the vnd/NK-2 gene can be activated in different ways in different neuroblasts, and that the pattern of vnd/NK-2 gene expression in neuroblasts of the ventral nerve cord is the sum of partial patterns.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Identification of Vnd/NK-2 expressing NBs in the ventral nerve cord. To identify the NBs expressing Vnd/NK-2, the enhancer trap NB marker Drosophila lines en-lacZ, wg-lacZ, and hkb5953 were used. In each line, β-Gal is expressed in identified NBs. Antibodies to Vnd/NK-2 protein (red) and β-Gal protein (green) were used for double staining. (A) Double-stained en-lacZ embryo at stage 11; β-Gal is expressed in the engrailed pattern in posterior compartment cells. NBs 1-2, 6-1, 7-1, and 7-2 were shown to express both Vnd/NK-2 and β-Gal proteins. The bar corresponds to 5 μm. (B) Double-stained wg-lacZ embryo at stage 11; NBs 5-1 and 5-2 are Vnd/NK-2 and β-Gal positive. (C) Double-stained hkb5953 embryo at stage 11; only NB 2-1 contains both Vnd/NK-2 and β-Gal proteins. (D) Schematic summary of the identity of Vnd/NK-2 positive NBs. At stage 11, the following nine NBs (orange centers) were identified that are Vnd/NK-2 positive per hemisegment: 1-2, 2-1, 3-1, 4-1, 5-1, 5-2, 6-1, 7-1, and 7-2. MP-2 and 1-1 also express Vnd/NK-2 earlier in development and are not shown here. Light blue, en-lacZ positive NBs; green, wg-lacZ positive NBs; purple, hkb5953 positive NBs (29).
Figure 2
Figure 2
Endogenous Vnd/NK-2 expression. β-Gal expression regulated by the −5.3/+0.35-kb DNA fragment from the 5′-upstream region of the vnd/NK-2 gene in neuroectoderm compared with NBs. Red, Vnd/NK-2 protein; green, β-Gal protein. (A) Neuroectoderm layer of a double-labeled embryo at early stage 11. A column of neuroectodermal cells, one cell wide, that contain NK-2 protein is seen on each side of the mesectoderm. The arrowhead points to an NB that is close to the neuroectoderm layer (possibly 6-1) that has a higher level of β-Gal expression than that of neuroectodermal cells. (B) NB layer of double-labeled embryo; β-Gal expression pattern (green), directed by vnd/NK-2 (−5.3/+0.35)-β-gal construct almost completely overlaps the endogenous Vnd/NK-2 pattern; however, Vnd/NK-2 but not β-Gal was expressed in NB 7-2 (arrow). The bar corresponds to 5 μm.
Figure 3
Figure 3
Regulatory DNA required for Vnd/NK-2 pattern formation in NBs. Fragments of DNA from the 5′-upstream region of the vnd/NK-2 gene, subcloned in the 5′-flanking region of an enhancerless β-gal gene in a P-element, were used to generate transgenic lines of Drosophila. Antibodies directed against Vnd/NK-2 protein (red) or β-Gal (green) were used to double-label NBs in the ventral nerve cord of stage 11 transgenic embryos. The neuroblasts are identified in the panels on the right. An NB with an orange center surrounded by a green ring expressed both Vnd/NK-2 and β-Gal. An NB that expressed Vnd/NK-2, but not β-Gal, is shown in red. Cells that ectopically express β-Gal are shown with white centers surrounded by green. (A) β-Gal expression regulated by the −5.3/−2.8-kb DNA fragment from the 5′-upstream region of the vnd/NK-2 gene in a transgenic embryo. The bar corresponds to 5 μm. (B) β-Gal expression regulated by the −4.7/−2.8-kb DNA fragment from the 5′-upstream region of the vnd/NK-2 gene. The arrow and arrowheads indicate cells (E1 and E2) that ectopically express β-Gal. (C) β-Gal expression regulated by the −4.0/−2.8-kb DNA fragment from the 5′-upstream region of the vnd/NK-2 gene. Arrowheads indicate the ectopic expression of β-Gal in E1 and E3 cells. (D) β-Gal expression regulated by the −5.3/−3.5-kb DNA fragment from the 5′-upstream region of the vnd/NK-2 gene. β-Gal is expressed strongly in two NB, 1-2 and 3-1, and weakly in NB 2-1 and NB 4-1. (E) β-Gal expression directed by the −5.3/−4.0-kb DNA fragment from the 5′-upstream region of the vnd/NK-2 gene in a transgenic embryo. The four NBs that express both β-Gal and Vnd/NK-2 shown in D also express both proteins in E; however, β-Gal expression in the embryo shown in E is weaker than the expression shown in D. The levels of expression of β-Gal in NBs 1-2 and 3-1 are greater than the expression found in NBs 2-1 and 4-1.
Figure 4
Figure 4
Summary of the analysis of vnd/NK-2 regulatory DNA. Five DNA fragments from the 5′-upstream region of the vnd/NK-2 gene were subcloned in the 5′-flanking region of an enhancerless β-gal gene in a P-element. The constructs were used to generate transgenic lines of Drosophila. The number of transgenic lines of flies generated for each construct is shown (enclosed by parentheses). DNA region A, −4.0 to −2.8 kb, is sufficient to direct Vnd/NK-2 expression in the following ten NBs: 1-1 (transient expression, not shown), 1-2, 2-1, 3-1, 4-1, 5-1, 5-2, 6-1, 7-1, and MP-2. In addition, region A activates ectopic Vnd/NK-2 expression in two cells, E1 and E3. DNA region B (B1 and B2, −5.3 to −4.0 kb) contains nucleotide sequences that activate the vnd/NK-2 gene in four NBs as follows: 1-2, 2-1, 3-1, and 4-1. DNA region B2 (−4.7 to −4.0 kb) activates the vnd/NK-2 gene ectopically in cell E2 and represses the vnd/NK-2 gene in E3. DNA region B1 (−5.3 to −4.7 kb) contains nucleotide sequences that repress the ectopic expression of the vnd/NK-2 gene in E1 and E2. Hypothesized DNA region C, whose location has not been identified, activates the vnd/NK-2 gene in NB 7-2. ML rep (−3.6 to −3.1 kb) corresponds to the region of DNA in the 5′-flanking region of the vnd/NK-2 gene that Estes et al. (18) have shown is required for midline repression of the vnd/NK-2 gene mediated indirectly by the Sim protein in mesoectodermal cells.

Similar articles

Cited by

References

    1. Kim Y, Nirenberg M. Proc Natl Acad Sci USA. 1989;86:7716–7720. - PMC - PubMed
    1. Nirenberg M, Nakayama K, Nakayama N, Kim Y, Mellerick D, Wang L-H, Webber K O, Lad R. Ann NY Acad Sci. 1995;758:224–242. - PubMed
    1. Jiménez F, Martin-Morris L E, Velasco L, Chu H, Sierra J, Rosen D R, White K. EMBO J. 1995;14:3487–3495. - PMC - PubMed
    1. Skeath J B, Panganiban G F, Carroll S B. Development (Cambridge, UK) 1994;120:1517–1524. - PubMed
    1. Weiss J B, Von Ohlen T, Mellerick D M, Dressler G, Doe C Q, Scott M P. Genes Dev. 1998;12:3591–3602. - PMC - PubMed

LinkOut - more resources